Forske på registerdata?
Hvis du ønsker å søke om data fra Norsk hjerteinfarktregister må du sende en søknad til Helsedataservice.
Helsedataservice forvalter Helsedata.no som er en felles søknadstjeneste for å få tilgang til helsedata fra ulike helseregistre.
For å søke om data til forskning er det utarbeidet to ulike søknadsskjema for utlevering av anonyme opplysninger og personidentifiserbare opplysninger. Mer informasjon om søknadsprosessen finner du her: Søknadsveiledning
Ta gjerne kontakt med sekretariatet i Norsk hjerteinfarktregister i forkant av en søknad for avklaringer, spørsmål eller veiledning om variabler og innhold i registeret. Epost: hjerteinfarktregisteret@stolav.no
Artikler som inkluderer data fra Norsk hjerteinfarktregister
2024
Bønaa KH, Halle KK, Govatsmark RES, Berge VB, Kiel AL, Sulo G, Kvåle R. Insidens og letalitet av akutt hjerteinfarkt i Norge 2013-21. Tidsskrift for Den norske legeforening 2024; 144(12).
https://doi.org/10.4045/tidsskr.24.0237
Kiel IA, Govatsmark RES, Berge VB, Halle KK, Lydersen S, Risøe C, Haug B, Jortveit J, Malm S, Singen GFT, Wiksnes M, Berg-Hansen CE, Nilsen LH, Moe EE, Bønaa KH. Datakvalitet i Norsk hjerteinfarktregister. Tidsskrift for Den norske legeforening 2024; 144.
https://doi.org/10.4045/tidsskr.23.0821
Jortveit J, Andersen GØ, Halvorsen S. Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: A nationwide cohort study 2013-2022. European Heart Journal. Acute Cardiovascular care 2024.
https://doi.org/10.1093/ehjacc/zuae121
2023
Halle KK, Digre TA, Govatsmark RES, Varmdal T. Coverage uncertainty range: A new method for calculating uncertainty around summary statistics in healthcare quality indicators. Norsk Epidemiologi 2023; 31 (1-2). https://doi.org/10.5324/nje.v31i1-2.5617
Uleberg B, Bønaa KH, Govatsmark RES, Olsen F, Jacobsen BK, Stensland E, Hauglann B, Vonen B, Førde OH. Exploring variation in timely reperfusion treatment in ST-segment elevation myocardial infarction in Norway: a national register-based cohort study. BMJ Open 2024; 14:e081301.
https://doi.org/10.1136/bmjopen-2023-081301
Forster RB, Kjellstadli C, Myklebust TA, Egeland G, Sulo G, Bjørge T, Bønaa KH, Juliusson TB, Kvåle R. Treatment and 30-Day Mortality after Myocardial Infarction in Prostate Cancer Patients: A Population-Based Study from Norway. Cardiology 2023; 148 (1): 83–92.
https://doi.org/10.1159/000527636
Kjellstadli C, Forster RB Myklebust TA, Bjørge T, Bønaa KH, Helle SI, Kvåle R. Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study. Frontiers in Oncology 2023; 13. https://doi.org/10.3389/fonc.2023.1121872
2022
Blöndal M, Ainla T, Eha J, Lõiveke P, Marandi T, Saar A, Veldre G, Edfors R, Lewinter C, Jernberg T, Jortveit J, Halvorsen S, Becker D, Csanádi Z, Ferenci T, Andréka P, Jánosi A. Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries. European Heart Journal - Quality of Care and Clinical Outcomes 2022; 8(3): 307–314.
https://doi.org/10.1093/ehjqcco/qcaa098
Edfors R, Jernberg T, Lewinter C, Blöndal M, Eha J, Lõiveke P, Marandi t, Ainla T, Saar A, Veldre G, Ferenci T, Andréka P, Jánosi A, Jortveit J, Halvorsen S. Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries. European Heart Journal - Quality of Care and Clinical Outcomes 2022; 8(4): 429-436. https://doi.org/10.1093/ehjqcco/qcab013
Hellgren T, Blöndal M, Jortveit J, Ferenci T, Faxén J, Lewinter C, Eha J, Lõiveke P, Marandi T, Ainla T, Saar A, Veldre G, Andréka P, Halvorsen S, Jánosi A, Edfors R. Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries. European Heart Journal Open 2022; 2(4). https://doi.org/10.1093/ehjopen/oeac042
Jortveit J, Sandberg EL, Pripp AH, Halvorsen S. Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction. Open Heart 2022; 9:e001934.
https://doi.org/10.1136/openhrt-2021-001934
Jortveit J, Pripp AH, Halvorsen S. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway. European Heart Journal - Cardiovascular Pharmacotheraphy 2022; 8(5): 442–451.
https://doi.org/10.1093/ehjcvp/pvab041
Kolden MØ, Nymo SH, Øie E. Impact of neighbourhood-level socioeconomic status, traditional coronary risk factors, and ancestry on age at myocardial infarction onset: A population-based register study. BMC Cardiovascular Disorders 2022; 22(1):447.
https://doi.org/10.1186/s12872-022-02880-7
2021
Hellgren T, Blondal M, Ainla T, Jortveit J, Eha J, Loiveke P, Marandi T, Saar A, Veldre G, Lewinter C, Halvorsen S, Ferenci T, Andreka P, Janosi A, Edfors R. Gender differences in characteristics, treatment and outcomes in ST elevation myocardial infarction patients in four European countries. European Heart Journal 2021; 42(1): ehab724.1114.
https://doi.org/10.1093/eurheartj/ehab724.1114
Varmdal T, Mathiesen EB, Wilsgaard T, Njølstad I, Nyrnes A, Grimsgaard S, Bønaa KH, Mannsverk J, Løchen ML. Validating Acute Myocardial Infarction Diagnoses in National Health Registers for Use as Endpoint in Research: The Tromsø Study. Clinical Epidemiology 2021; 13:675–682.
https://doi.org/10.2147/CLEP.S321293
2020
Jortveit J, Halvorsen S, Langørgen J. Pharmacy-dispensed drugs for secondary prevention after myocardial infarction. Tidsskriftet for Den Norske Legeforening 2020; 140(4): 355-360.
https://doi.org/10.4045/tidsskr.19.0416
Jortveit J, Pripp AH, Langørgen J, Halvorsen S. Incidence, risk factors and outcome of young patients with myocardial infarction. Heart 2020; 106:1420–1426.
https://doi.org/10.1136/heartjnl-2019-316067
Jortveit J, Pripp AH, Halvorsen S. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway. European Heart Journal - Cardiovascular Pharmacotherapy 2022; 8(5): 442-451.
https://doi.org/10.1093/ehjcvp/pvab041
Halle KK, Govatsmark RES, Digre TA, Sneeggen SF, Bønaa KH. Regionale forskjeller i behandling av akutt hjerteinfarkt 2013-2018 – Resultater fra Norsk hjerteinfarktregister. Hjerteforum 2020; 33(2):51-58. Hjerteforum
Rice E, Solheim E, Lystad R, Kjøpstad M, Thyri EK, Gravdal JO. Tid til trombolyse ved STEMI - et kvalitetsforbedringsprosjekt i Helse Møre og Romsdal. Hjerteforum 2020; 33(3):40-48. Hjerteforum
2019
Jortveit J, Halvorsen S, Kaldal A, Pripp AH, Govatsmark RE, Langørgen J. Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease. BMC Cardiovascular Disorders 2019; 19:71.
https://doi.org/10.1186/s12872-019-1062-y
Arnesen JS, Strøm KH, Bønaa KH, Wiseth R. Behandling av hjerteinfarkt med ST-elevasjon - en observasjonsstudie. Tidsskrift for Den norske Legeforening 2019; 139(17).
https://doi.org/10.4045/tidsskr.18.0928
Jortveit J, Pripp AH, Langørgen J, Halvorsen S. Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction. European Journal of Preventive Cardiology 2019; 26(13):1373-1382.
https://doi.org/10.1177/2047487319841940
2018
Bønaa KH, Govatsmark RES, Digre T, Sneeggen S, Halle KH. Norsk hjerteinfarktregister - kompletthet, datakvalitet og resultater for 2016. Hjerteforum 2018; 31(2);42-48. Hjerteforum
Govatsmark RES, Janszky I, Slørdahl SA, Ebbing M, Wiseth R, Grenne B, Vesterbekkmo E, Bønaa KH. Completeness and correctness of acute myocardial infarction diagnoses in a medical quality register and an administrative health register. Scandinavian Journal of Public Health 2018; 48(1):5-13.
https://doi.org/10.1177/1403494818803256
Strøm KH, Arnesen JS. ST-segment elevation myocardial infartction in Mid-Norway health region. A comparison of fibrinolytic therapy and primary PCI. Graduate thesis in Medicine 2018, Trondheim.
2017
Jortveit J, Halvorsen S. Geographical differences in prescription of secondary preventive drug therapy after acute myocardial infarction in Norway. European Heart Journal - Cardiovascular Pharmacotherapy 2017; 3(3):132–33.
https://doi.org/10.1093/ehjcvp/pvx008
Bønaa KH. Norsk hjerteinfarktregister. Indremedisineren 2017; 1:24-9. Indremedisineren
Bønaa KH, Steigen T. Koronar angiografi ved akutt hjerteinfarkt uten ST-elevasjon - hvem og når? Tidsskrift for Den norske legeforening 2017; 137(22).
https://doi.org/10.4045/tidsskr.17.0492
2016
Jortveit J, Govatsmark RE, Langorgen J, Hole T, Mannsverk J, Olsen S, Risøe C, Halvorsen S. Kjønnsforskjeller i utredning og behandling av hjerteinfarkt. Tidsskrift for Den norske legeforening 2016; 136(14-15):1215-22.
https://doi.org/10.4045/tidsskr.16.0224
Govatsmark RE, Sneeggen S, Karlsaune H, Slordahl SA, Bonaa KH. Interrater reliability of a national acute myocardial infarction register. Clinical Epidemiology 2016; 8:305-12.
https://doi.org/10.2147/CLEP.S105933.eCollection 2016
Haug B, Rolstad OJ, Vegsundvåg J. Fremtidens PCI-behandling etter hjerteinfarkt. Tidsskrift for Den norske legeforening 2016; 136:1612-13.
https://doi.org/10.4045/tidsskr.16.0763
Øie, E. Over 80 år og hjerteinfarkt. Tidsskrift for Den norske legeforening 2016; 136:1058.
https://doi.org/10.4045/tidsskr.16.0458
2014
Jortveit J, Govatsmark RE, Digre T, Risøe C, Hole T, Mannsverk J, Slørdahl S, Halvorsen S. Hjerteinfarkt i Norge i 2013. Tidsskrift for Den norske legeforening 2014; 134(19):841-6.
https://doi.org/10.4045/tidsskr.14.0804
Jortveit J, Grenne B, Uchto M, Dahlslett T, Fosse L, Gunnes P. Følges retningslinjene for behandling av hjerteinfarkt? Tidsskrift for Den norske legeforening 2014; 134(4):412-6.
https://doi.org/10.4045/tidsskr.13.0305
Thelle DS. Endelig et norsk hjerteinfarktregister. Tidsskrift for Den norske legeforening 2014; 134(19):1818.
https://doi.org/10.4045/tidsskr.14.1148